CN109957576A - A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application - Google Patents
A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application Download PDFInfo
- Publication number
- CN109957576A CN109957576A CN201910225983.1A CN201910225983A CN109957576A CN 109957576 A CN109957576 A CN 109957576A CN 201910225983 A CN201910225983 A CN 201910225983A CN 109957576 A CN109957576 A CN 109957576A
- Authority
- CN
- China
- Prior art keywords
- plasmid
- pfc330
- bec
- base
- achieve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 80
- 230000035772 mutation Effects 0.000 title claims abstract description 40
- 241000228245 Aspergillus niger Species 0.000 claims abstract description 39
- 241000233866 Fungi Species 0.000 claims abstract description 29
- 239000012634 fragment Substances 0.000 claims abstract description 18
- 230000002068 genetic effect Effects 0.000 claims abstract description 18
- 241000588724 Escherichia coli Species 0.000 claims abstract description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 11
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 11
- 101150078331 ama-1 gene Proteins 0.000 claims abstract description 8
- 230000004927 fusion Effects 0.000 claims abstract description 8
- 230000003362 replicative effect Effects 0.000 claims abstract description 8
- 101150054232 pyrG gene Proteins 0.000 claims abstract description 6
- 108020005091 Replication Origin Proteins 0.000 claims abstract description 4
- 238000005457 optimization Methods 0.000 claims description 8
- 108020001507 fusion proteins Proteins 0.000 claims description 5
- 102000037865 fusion proteins Human genes 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 3
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 101150025342 UGI gene Proteins 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 210000001541 thymus gland Anatomy 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 37
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 abstract description 10
- 230000002779 inactivation Effects 0.000 abstract description 10
- 150000001413 amino acids Chemical class 0.000 abstract description 9
- 238000010353 genetic engineering Methods 0.000 abstract description 9
- 230000009466 transformation Effects 0.000 abstract description 6
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 abstract description 5
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 229940104230 thymidine Drugs 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 4
- 230000001488 breeding effect Effects 0.000 abstract description 4
- 239000002207 metabolite Substances 0.000 abstract description 2
- 230000001766 physiological effect Effects 0.000 abstract description 2
- 239000002585 base Substances 0.000 description 55
- 108020004414 DNA Proteins 0.000 description 26
- 238000000034 method Methods 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 17
- 230000029087 digestion Effects 0.000 description 16
- 101150115781 prtT gene Proteins 0.000 description 12
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 10
- 241001370055 Aspergillus niger CBS 513.88 Species 0.000 description 10
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 108091033409 CRISPR Proteins 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- 238000013467 fragmentation Methods 0.000 description 6
- 238000006062 fragmentation reaction Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229940035893 uracil Drugs 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- 102220605874 Cytosolic arginine sensor for mTORC1 subunit 2_D10A_mutation Human genes 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 4
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 108700005075 Regulator Genes Proteins 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000009615 deamination Effects 0.000 description 3
- 238000006481 deamination reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010362 genome editing Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000006780 non-homologous end joining Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 240000006439 Aspergillus oryzae Species 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- 238000007702 DNA assembly Methods 0.000 description 2
- 230000007018 DNA scission Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 101150008194 argB gene Proteins 0.000 description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AILDTIZEPVHXBF-UHFFFAOYSA-N Argentine Natural products C1C(C2)C3=CC=CC(=O)N3CC1CN2C(=O)N1CC(C=2N(C(=O)C=CC=2)C2)CC2C1 AILDTIZEPVHXBF-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 238000010453 CRISPR/Cas method Methods 0.000 description 1
- 102100026846 Cytidine deaminase Human genes 0.000 description 1
- 108010031325 Cytidine deaminase Proteins 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 229940113491 Glycosylase inhibitor Drugs 0.000 description 1
- 101100313266 Mus musculus Tead1 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 244000308495 Potentilla anserina Species 0.000 description 1
- 235000016594 Potentilla anserina Nutrition 0.000 description 1
- 102100025292 Stress-induced-phosphoprotein 1 Human genes 0.000 description 1
- 101150074253 TEF1 gene Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000011090 industrial biotechnology method and process Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003588 threonines Chemical class 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base and its applications.The nucleotide sequence of the pFC330-BEC plasmid is as shown in SEQ ID NO:3, and it includes the rAPOBEC1-XTEN-nCas9-UGI fusion segment that can be expressed in aspergillus niger, E. coli resistance genetic fragment AmpR, pyrG selection markers, filamentous fungi autonomously replicating sequence AMA1, promoter Ptef and plasmid replication origin ori.The cytimidine in any site on filamentous fungi genome efficiently and quickly can be mutated into thymidine by the plasmid, can be realized the mutation of amino acid or the inactivation of gene.The plasmid the molecular breeding of filamentous fungi, physiological property, metabolite, host transformation, in terms of have broad application prospects, can for filamentous fungi genetic engineering transformation provide new technology platform.
Description
Technical field
The invention belongs to genetic engineering fields, and in particular to a kind of pFC330-BEC matter for being able to achieve the accurate point mutation of base
Grain and its application.
Background technique
CRISPR/Cas system with accurate edits genomic DNA characteristic has been that the development of genetic engineering brings leather
The impetus of life property.Endonuclease Cas9 is directed to specific base under the guidance of single chimeric guidance RNA (sgRNA)
Because of seat, it identifies and cuts in a targeted manner specific dna sequence in the locus, and double-strand break is generated in genome
(DSB).In cell, DSB mainly carries out DNA double chain reparation by way of non-homologous end joining (NHEJ);In donor dna
In the presence of, DSB can also activate homologous recombination repair (HDR) to carry out accurate genetic modification, but its efficiency is lower than high
NHEJ in eukaryocyte.The gene inactivation carried out by DSB be easy to cause to induce in protein coding gene to be inserted into frame
Missing, still there may be functional protein and frameshit insertion and deletion, so as to cause that with immunogenicity and may have not
Know the translation of the outer frame polypeptide sequence of effect.Therefore, it is necessary to the methods that accurate edits genome avoids DSB simultaneously.
It in order to avoid DNA damage during gene editing and eliminates the needs of HDR donor template is provided, Komor et al. exists
A kind of new method for being known as " gene editing device " (BE) is developed in mammalian cell.In the base editing system, use
Rat cytidine deaminase (rAPOBEC1) and uracil glycosylase enzyme inhibitor (UGI) are by Cas9 mutant (D10A or D10A&
H840A) engineering, which may be implemented cytimidine (C) can be completed without DSB in target site, is converted into uracil (U).This base
Because the advantages of group edit methods, is that it does not need double-strand DNA cleavage or donor dna template not only, but also can be straight in the editing window
Editor's single nucleotide acid is connect, amino acid mutation or gene inactivation are completed.CRISPR/nCas9 base editing system because it is simple,
Efficiently, the Genomic damage of low off-target rate and reduction, is widely used to mammalian cell recently, zebra fish, plant and thin
Genome editor in bacterium.However, there are no construct and answer about CRISPR/nCas9 base editing system in filamentous fungi
Report.
Aspergillus niger is a kind of well-known model organism for being used to study filamentous fungi biology, and natural polymer secretes energy
Power is used in industrial biotechnology for a long time, for producing homologous and heterologous protein expression.Microbiological genetic engineering
Development enables Microbial Breeding to free from conventional method, such as ultraviolet mutagenesis and chemical reagent mutagenesis.Using
The research to gene function and genetic engineering is accelerated in the genome edit tool CRISPR/Cas9 of filamentous fungi.However,
During filamentous fungi genetic modification, the FAQs of CRISPR/Cas9 system (DSB and need donor dna) is still had.
Summary of the invention
In order to overcome the deficiencies of the prior art, the present invention provides a kind of pFC330-BEC for being able to achieve the accurate point mutation of base
Plasmid and its application.The plasmid (pFC330-BEC) can be efficiently and quickly by filamentous fungi (such as Aspergillus niger strain)
The cytimidine in any site on genome is mutated into thymidine, can be realized the mutation of amino acid or the inactivation of gene.
We develop a base using rat rAPOBEC1 deaminase fusion nCas9 and UGI albumen in aspergillus niger
Editing system (application method of pFC330-BEC plasmid) provides a kind of simple and efficient base editing side for aspergillus niger
Method.
The purpose of the present invention is realized at least through one of following technical solution.
A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base provided by the invention, nucleotide sequence such as SEQ
Shown in ID NO:3.
Further, the pFC330-BEC plasmid, containing through aspergillus niger codon optimization and can in aspergillus niger table
The genetic fragment and filamentous fungi autonomously replicating sequence AMA1 of the rAPOBEC1-XTEN-nCas9-UGI reached.
Further, the rAPOBEC1-XTEN-nCas9-UGI fusion segment includes artificial synthesized and through black
The rAPOBEC1-XTEN genetic fragment (SEQ ID NO:1) and UGI genetic fragment (SEQ ID NO:2) of aspergillus codon optimization.
Further, the rAPOBEC1-XTEN-nCas9-UGI fusion segment, is able to use aspergillus fumigatus source
Tef1 gene promoter Ptef driving ( C S,Nielsen J B,Kogle M E,et al.A CRISPR-
Cas9system for genetic engineering of filamentous fungi[J].PLoS One,2015,10
(7): e0133085.), so that it is expressed in aspergillus niger.
Further, the pFC330-BEC plasmid includes the site BglII that can be used to be inserted into sgRNA segment, can be inserted
Enter sgRNA;The sgRNA of insertion is responsible for guiding rAPOBEC1-nCas9-UGI fusion protein in the specific editor position of genome.
Further, the pFC330-BEC plasmid includes pyrG selection markers and the filiform that can be realized mark cycle
Fungi autonomously replicating sequence AMA1.
Further, the pFC330-BEC plasmid is also containing the plasmid replication origin ori and large intestine bar in Escherichia coli
Bacterium ampicillin resistance gene segment AmpR, the AmpR are the ampicillin resistance genes (AmpR) of Escherichia coli,
PFC330-BEC plasmid needs to be transferred to Escherichia coli and expands culture period, and Gene A mpR can be used as pFC330-BEC matter
The label of grain, to realize screening and expansion culture of the pFC330-BEC plasmid in Escherichia coli.
The pFC330-BEC plasmid that the accurate point mutation of base is able to achieve described in present invention offer carries out alkali in filamentous fungi
The application of base editor.
Further, the filamentous fungi includes aspergillus niger.
Preferably, the aspergillus niger is aspergillus niger CBS513.88 bacterial strain or aspergillus niger FGSC1279 bacterial strain.
Further, the base editor includes the editor that cytimidine sports thymidine.
Further, the rAPOBEC1 genetic fragment is derived from rat (rat), can express cytimidine (C) deamination
Enzyme, the XTEN genetic fragment are the hinge regions (linker) of 16 amino acid, and base sequence is by aspergillus niger password
Son optimization, DNA sequence dna are as follows: 5'-agcggttccgagaccccgggcaccagcgaatccgccacccccgagtcc-3';
Its function is to carry out deamination to cytimidine C in DNA sequence dna to form uracil (U).
UGI genetic fragment of the present invention is uridine glycosylase repressor (uracil glycosylase
Inhibitor abbreviation), can express UGI albumen, and the UGI albumen is able to suppress the C after deaminase rAPOBEC1 modification
(being mutated into U in fact) independently repairs through DNA and reverts back to C.
The nucleotide for the rAPOBEC1-XTEN genetic fragment (rAPOBEC1-XTEN (optimized)) that the present invention uses
Sequence is as shown in SEQ ID NO:1, the nucleotide sequence such as SEQ ID NO:2 institute of the UGI genetic fragment (UGI (optimized))
Show;The rAPOBEC1-XTEN genetic fragment and UGI genetic fragment pass through aspergillus niger codon optimization, can be in aspergillus niger
Middle normal expression.
The filamentous fungi autonomously replicating sequence AMA1 of the present invention that can be realized mark cycle is existing literature report,
Its function is to realize that plasmid realizes autonomous duplication in filamentous fungal cells, and the document in source is shown in C S,Nielsen
J B,Kogle M E,et al.A CRISPR-Cas9system for genetic engineering of
filamentous fungi[J].PLoS One,2015,10(7):e0133085.。
In application method provided by the invention, the process of the base editor are as follows: pFC330-BEC plasmid is transferred to aspergillus niger
Afterwards, promoter Ptef drives the expression of fusion protein rAPOBEC1-nCas9-UGI, and wherein it is single-stranded to be responsible for DNA for nCas9 albumen
Cutting, rAPOBEC1 albumen are responsible for the deamination to cytimidine (C), and the function that UGI albumen inhibits DNA itself to repair, this melts
Hop protein targets target gene under the guidance of the sgRNA introduced by the site BglII, realizes that target gene is pinpoint
Base mutation function.
The present invention provides not only above-mentioned plasmid and additionally provides using the plasmid the new of in filamentous fungi base mutation
Method, and if it works, it will promote the accuracy of its molecular breeding well.
Compared with prior art, the invention has the advantages that and the utility model has the advantages that
PFC330-BEC plasmid provided by the invention can be efficiently and quickly by appointing on various aspergillus niger genomes
The cytimidine in meaning site is mutated into thymidine, realizes amino acid mutation and gene inactivation etc.;The pFC330-BEC plasmid exists
The molecular breeding of aspergillus niger, physiological property, metabolite, host's transformation, industrial production etc. have broad application prospects,
New technology platform is provided for the transformation of aspergillus niger genetic engineering.
Detailed description of the invention
Fig. 1 is the pFC330-BEC plasmid construct schematic diagram provided by the invention for being able to achieve the accurate point mutation of base;
Fig. 2 is real in aspergillus niger CBS513.88 bacterial strain using the pFC330-BEC plasmid in the embodiment of the present invention two
Now to the sequencing result figure of protease regulator gene prtT base editor;
Fig. 3 is to be realized in aspergillus niger FGSC1279 bacterial strain to color in the embodiment of the present invention three using pFC330-BEC plasmid
The result sequencer map of plain controlling gene fwnA base editor;
Fig. 4 is to make pigment tune in aspergillus niger FGSC1279 bacterial strain using FC330-BEC plasmid in the embodiment of the present invention three
Control the phenotype plate of gene fwnA inactivation.
Specific embodiment
Specific implementation of the invention is described further below in conjunction with attached drawing and example, but implementation and protection of the invention
It is without being limited thereto.If it is existing to be that those skilled in the art can refer to it is noted that there is the not special process of detailed description below
Technology realize or understand.Reagents or instruments used without specified manufacturer, be considered as can by it is commercially available be commercially available it is normal
Advise product.
Molecular biology experiment technology employed in following embodiment includes PCR amplification, plasmid extraction, DNA fragmentation
The technical operations such as digestion, connection, gel electrophoresis referring specifically to " Molecular Cloning:A Laboratory guide " (third edition) (Sambrook J,
Russell DW, Janssen K, Argentine J. Huang Peitang etc. is translated, and 2002, Beijing: Science Press).
According to Komor et al., 2016 rAPOBEC1 reported in the literature, the nucleotide sequence of the segments such as XTEN, UGI
(Komor,A.C.,Kim,Y.B.,Packer,M.S.,Zuris,J.A.,&Liu,D.R.(2016).Programmable
editing of a target base in genomic DNA without double-stranded DNA
Cleavage.Nature, 533 (7603), 420.), bibliography provide aspergillus niger codon optimization table (Yin, C., Wang,
B.,He,P.,Lin,Y.,&Pan,L.(2014).Genomic analysis of the aconidial and high-
performance protein producer,industrially relevant Aspergillus niger
SH2strain.Gene, 541 (2), 107-114.), the rAPOBEC1- of commission Nanjing Genscript Biotechnology Co., Ltd. synthesis
The nucleotide sequence of XTEN and UGI, specific nucleotide sequence are respectively SEQ ID NO:1 and SEQ ID NO:2;It is described
RAPOBEC1-XTEN and UGI nucleotide sequence passes through aspergillus niger codon optimization.
Embodiment one, genetic recombination building pFC330-BEC recombinant plasmid (pFC330-BEC plasmid)
The primer sequence used in embodiment one such as the following table 1 (synthesizes) in Guangzhou Tian Yihuiyuan Biotechnology Co., Ltd:
Table 1
The composition of pFC330-BEC recombinant plasmid is as shown in Figure 1, wherein the site BglII: for being inserted into sgRNA segment;
Ptef: aspergillus fumigatus source tef1 gene promoter, for driving expressing fusion protein;AmpR: ampicillin resistance gene;
Ori: the plasmid replicon (replication origin) in Escherichia coli;PyrG: uracil auxotrophy label;AMA1: filamentous fungi
Autonomously replicating sequence;RAPOBEC1: the cytosine deaminase of codon optimization;NCas9:10 amino acids are mutated (D10A's)
Cas9 albumen;UGI: uracil dna glycosylase inhibits albumen.
The pFC330-BEC recombinant plasmid contains the rAPOBEC1-nCas9-UGI genetic fragment that can be expressed and silk
Shape fungi autonomously replicating sequence AMA1, the sequence of the recombinant plasmid (pFC330-BEC plasmid) is as shown in SEQ ID NO:3.
The building of pFC330-BEC recombinant plasmid, comprises the following steps that
1, it (is purchased from restriction enzyme PacI (being purchased from New England Biolabs (Beijing) LTD.) and PmlI
New England Biolabs (Beijing) LTD.) to pFC330 plasmid (C.S.,Nielsen,J.B.,
Kogle,M.E.,&Mortensen,U.H.(2015).A CRISPR-Cas9 system for genetic engineering
Of filamentous fungi.PLoS One, 10 (7), e0133085.) double digestion is carried out, through gel electrophoresis, gel extraction
Linearized nucleic acid piece containing pyrG label, ampicillin resistance gene AmpR and filamentous fungi autonomously replicating sequence AMA1
Section;
2, it using pFC330 plasmid as template, expands to obtain nCas9 segment by primer pair cas9-10GCT-F and cas9-R;
By primer pair Ptef-pacI+20bp-F and Ptef-R (20bp), primer pair Ttef-F and Ttef-PmlI+20bp-R are expanded
To Ptef and Ttef segment, (it is purchased from Thermo, article No. by PCR product QIAquick Gel Extraction Kit: 00524864) returned PCR product
It receives;
3, using artificial synthesized rAPOBEC1-XTEN segment as template, pass through primer pair rAPOBEC1-F and rAPOBEC1-
R expands to obtain the rAPOBEC1-XTEN segment containing fusion connector;
4, it using artificial synthesized UGI segment as template, expands to obtain by primer pair SGGS-UGI-F and SGGS-UGI-R
UGI segment containing fusion connector;(concrete operation method is shown in the Hifi DNA Assembly Master of NEBuilder company
The specification of Mix)
5, with Infusion method, (concrete operation method is shown in the Hifi DNA Assembly of NEBuilder company
The specification of Master Mix) DNA fragmentation obtained in step 1-4 connected into circular plasmids, building obtains nCas9 base volume
It collects plasmid pFC330-BEC (pFC330-rAPOBEC1-XTEN-nCAS9-UGI).The plasmid is first passed through chemical transformation to be transferred to
Escherichia coli (E.coli MatchI TI), obtain positive colony, plasmid are extracted after being sequenced, obtain pFC330-BEC plasmid
(i.e. pFC330-BEC plasmid vector).
Embodiment two, pFC330-BEC plasmid realize efficient base editor in aspergillus niger CBS513.88 bacterial strain:
It can be realized in aspergillus niger CBS513.88 bacterial strain with pFC330-BEC plasmid and the efficient base of different genes is compiled
Volume.For having chosen the prtT gene (protease regulator gene prtT) of aspergillus niger in experiment, in aspergillus niger CBS513.88 bacterial strain
Middle progress base editor's experiment.
Fig. 2 is real in aspergillus niger CBS513.88 bacterial strain using the pFC330-BEC plasmid in the embodiment of the present invention two
Now to the sequencing result figure of protease regulator gene prtT base editor.
Wherein the DNA sequence dna (TTTGATTAAAAGCATCATCA) in Fig. 2 box is protospacer sequence (20bp);
Box above sequencer map is corresponding amino acid;Arrow indicates the site of mutation;Right side box is the amino to mutate
Sour position and corresponding transformant number.
Embodiment two carries out base using the prtT gene in pFC330-BEC plasmid pair aspergillus niger CBS513.88 bacterial strain and dashes forward
Become, 142 threonines (T) is mutated into isoleucine (I), while having also appeared the DNA sequencing result of same sense mutation;Specifically
The threonine (T) of No. 142 positions is mutated into including being completed by the way that two C of No. 6,7 positions in protospacer are mutated into T
Isoleucine (I);The single base mutation of No. 7 positions is had also appeared simultaneously, this sports same sense mutation.
1, a NGG (any base of N expression, G are first selected on the target gene prtT of aspergillus niger CBS513.88 bacterial strain
For guanine base) DNA fragmentation of 20 bases before sequence (20 bases are referred to as protospacer).This step
It is characterized in that, the cytimidine C for needing to mutate should be located at the position 2-8 of upper 20 bases of protospacer (with 5' → 3'
Sequential counting).Such as test the DNA sequence dna of selected prtT gene protospacer are as follows: 5'-
TTTGACCAAAAGCATCATCA-3', wherein the cytimidine C (underscore overstriking) that base editor may occur is No. 6 positions and No. 7
Position.
2, it is synthesized by Guangzhou Ai Ji Bioisystech Co., Ltd containing the protospacer sequence and can be in filiform
The sgRNA (prtT-sgRNA) of normal transcription in fungi, particular sequence is as shown in SEQ ID NO:4.
3, to enable sgRNA segment to be inserted into pFC330-BEC plasmid, the amplification containing BglII restriction enzyme site need to be designed
Primer, particular sequence are as follows:
Forward primer PU6-F:
5'-GAAGATCTTCGCAGGCGGTTGCAAGCGATC-3';
Reverse primer TU6-R:
5'-GAAGATCTTCAGCAGCTCTATATCACGTGACG-3';
In Guangzhou, Tian Yihuiyuan Biotechnology Co., Ltd synthesizes above-mentioned two primers, and expands according to the procedure below
PrtT-sgRNA:
98℃5min;98 DEG C of 30s, 62 DEG C of 30s, 72 DEG C of 30s;Totally 30 recycle, then 72 DEG C of 5min;Last 25 DEG C, 1s;
PrtT-sgRNA amplified production is the identification of 1% agarose gel electrophoresis through mass fraction, is recycled with PCR product QIAquick Gel Extraction Kit pure
Change PCR product.
By the prtT-sgRNA amplified production of recycling, digestion is carried out according to following condition:
Template 40ul, FD buffer 5ul (is purchased from Thermol, article No.: FD0083), and restriction endonuclease BglII5ul (is purchased from
Thermol, article No.: FD0083), 37 DEG C 2 hours.
After digestion, digestion products are recycled with PCR product QIAquick Gel Extraction Kit, are obtained containing BglII digestion cohesive end
PrtT-sgRNA segment;
4, the pFC330-BEC plasmid vector constructed in embodiment one is extracted, carries out single endonuclease digestion with restriction endonuclease BglII, is obtained
Linearized vector.Its reaction system is as follows: 5ul FD buffer (is purchased from Thermol, article No.: FD0083), 2.5ul BglII
(being purchased from Thermol, article No.: FD0083), 2.5ul fastAP (dephosphorylation) (are purchased from Thermol, article No.: EF0651),
PFC330-BEC plasmid 40ul (includes 10ug Plasmid DNA).37 DEG C are reacted 8 hours, and linearisation pFC330-BEC carrier is obtained.
5, using DNA fragmentation connection kit (DNA Ligation Kit Ver 2.1, article No.: 6022) will linearisation
PFC330-BEC carrier and the prtT-sgRNA containing BglII cohesive end connect into a cyclic plasmid pFC330-BEC-
prtTsgRNA.Connection product (cyclic plasmid pFC330-BEC-prtTsgRNA) is transformed into the Escherichia coli of competence
MatchI TI (is purchased from Takara company), and picking transformant is in liquid LB+Amp (100 μ g/ml of final concentration) after 37 DEG C of culture 12h
Culture medium, under the conditions of 37 DEG C, shaking speed be that 200rpm cultivates 12h, be bacterium solution PCR, preliminary screening goes out positive transformant.By bacterium
The positive transformant that liquid PCR is screened extracts plasmid processing, digestion verification, selects 2 plasmid sizes correctly and digestion verification
Correct positive transformant, is sequenced.It compares after taking sequencing result with template sequence, obtains correct pFC330-
BEC-prtTsgRNA base editor's carrier.
6, expression of the prtT gene base editor carrier in aspergillus niger CBS513.88: according to (Gomi K, Iimura Y,
Hara S.Integrative transformation of Aspergillus oryzae with a plasmid
containing the Aspergillus nidulans argB gene[J].Agricultural and biological
Chemistry, 1987,51 (9): 2549-2555.) in provide the step of, prepare host strain aspergillus niger CBS513.88 (Δ ku Δ
The base editor's carrier pFC330-BEC-prtTsgRNA plasmid obtained above that obtains is transformed into original by protoplast pyrG)
In raw plastid, hypertonic CD culture medium is coated with (comprising 1M sucrose, 0.3% (w/v) NaNO3, 0.2% (w/v) KCl, 0.05% (w/
v)MgSO4.7H2O, 0.1% (w/v) K2HPO4.3H2O, 0.001% (w/v) FeSO4.7H2O, 2% (w/v) agar powder, pH5.5,
The unit of w/v is g/mL), 30 DEG C of incubators are put into, observe transformant growing state after 5d.
7, it aspergillus niger transformant target site PCR and Sanger sequencing: after above-mentioned transformant is grown on hypertonic CD plate, chooses
It (include 2% (w/v) glucose, 0.3% (w/v) NaNO to new common CD solid plate3, 0.2% (w/v) KCl, 0.05% (w/
v)MgSO4.7H2O, 0.1% (w/v) K2HPO4.3H2O, 0.001% (w/v) FeSO4.7H2O, 2% (w/v) agar powder, pH
5.5, w/v unit is g/mL), it is put into 30 DEG C of incubator culture 5d and grows up to bacterium colony, after bacterium colony is grown up, extract conversion subbase
Because of group, prtT Gene Partial is expanded as pcr template.Design prtT partial sequence amplimer:
Forward primer prtT-BE-F:
5'-ATGCGTGCCGTCGCTGTCTA-3'
Reverse primer prtT-BE-R:
5'-CAGCCGTTTCATTGTCCACCA-3'
In Guangzhou, Tian Yihuiyuan Biotechnology Co., Ltd synthesizes above-mentioned two primers, and expands prtT according to the procedure below
Partial sequence:
98℃5min;98 DEG C of 30s, 60 DEG C of 30s, 72 DEG C of 50s;Totally 30 recycle, then 72 DEG C of 5min;Last 25 DEG C, 1s;
Amplified production is that 1% agarose gel electrophoresis is identified through mass fraction, with PCR product QIAquick Gel Extraction Kit recovery purifying PCR product,
And PCR product is sent to Guangzhou Tian Yihuiyuan Bioisystech Co., Ltd sequence verification.
Experimental result discovery has 3 transformants that the mutation in No. 6 sites occurs, there is 6 in 15 transformants of selection
No. 6 and No. 7 double mutation occur, sequencing result is as shown in Figure 2.
Embodiment three, pFC330-BEC plasmid realize efficient base editor in aspergillus niger FGSC1279 bacterial strain:
It can be realized in aspergillus niger FGSC1279 bacterial strain to the efficient base editor of different genes with pFC330-BEC plasmid.
For having chosen pigment gene fwnA gene in experiment, base editor experiment (result is carried out in aspergillus niger FGSC1279 bacterial strain
See Fig. 3 and Fig. 4).Fig. 3 is that the fwnA gene in pFC330-BEC plasmid pair aspergillus niger FGSC1279 bacterial strain carries out base mutation survey
Sequence result figure;
Wherein the DNA sequence dna (GGTAATTGAGCATTTACGCC) in Fig. 3 box is protospacer sequence (20bp);
Box above sequencer map is corresponding amino acid;Arrow indicates the site of mutation;Right side box is the amino to mutate
Sour position and corresponding transformant number.
It is completed by the way that the C of in protospacer 6, No. 7 positions is mutated into T and the arginine of No. 557 positions is mutated into termination
Codon, No. 556 positions are same sense mutation;Have also appeared the single base mutations of No. 7 positions simultaneously, the mutation is by the smart ammonia of No. 557 positions
Acid mutation realizes gene inactivation at terminator codon;Fig. 4 is using FC330-BEC plasmid in the embodiment of the present invention three black
The phenotype plate for inactivating pigment controlling gene fwnA in aspergillus FGSC1279 bacterial strain, wherein the wt in the upper right corner is wild strain, herein
Phenotype group after (wt) as a control group, with fwnA gene inactivation compares.As can be seen from Figure 4, the wild strain of control produces black spore
Son;Massive plate is 9 plants of mutant strains by single base inactivation, and fwnA gene inactivates the generation for leading to white spore.
1, some NGG is first selected on the target gene fwnA of aspergillus niger FGSC1279 bacterial strain, and (N indicates any base, G
For guanine base) DNA fragmentation of 20 bases before sequence (20 bases are referred to as protospacer).This step
It is characterized in that, the cytimidine C for needing to mutate should be located at the position 2-8 of upper 20 bases of protospacer (with 5' → 3'
Sequential counting).Such as test the DNA sequence dna of selected fwnA gene protospacer are as follows: 5'-
GGTAACCGAGCATTTACGCC-3', wherein the cytimidine C (underscore overstriking) that base editor may occur is No. 6 positions and No. 7
Position.
2, synthesis containing the protospacer sequence and can in filamentous fungi normal transcription sgRNA (fwnA-
SgRNA), particular sequence is shown in SEQ ID NO:5.
3, to enable sgRNA segment to be inserted into pFC330-BEC plasmid, the amplification containing BglII restriction enzyme site need to be designed
Primer, particular sequence are as follows:
Forward primer PU6-F:
5'-GAAGATCTTCGCAGGCGGTTGCAAGCGATC-3';
Reverse primer TU6-R:
5'-GAAGATCTTCAGCAGCTCTATATCACGTGACG-3';
In Guangzhou day, the biological Co., Ltd of the remote science and technology of a brightness synthesizes above-mentioned two primers, and expands according to the procedure below
FwnA-sgRNA:
98℃5min;98 DEG C of 30s, 62 DEG C of 30s, 72 DEG C of 30s;Totally 30 recycle, then 72 DEG C of 5min;Last 25 DEG C, 1s;
FwnA-sgRNA amplified production is the identification of 1% agarose gel electrophoresis through mass fraction, is recycled with PCR product QIAquick Gel Extraction Kit pure
Change PCR product.
By the fwnA-sgRNA amplified production of recycling, digestion is carried out according to following condition:
Template 40ul, FD buffer 5ul (is purchased from Thermol, article No.: FD0083), and restriction endonuclease BglII 5ul (is purchased from
Thermol, article No.: FD0083), 37 DEG C 2 hours.
After digestion, digestion products are recycled with PCR product QIAquick Gel Extraction Kit.It obtains containing BglII digestion cohesive end
FwnA-sgRNA segment.
4, the pFC330-BEC plasmid vector constructed in embodiment one is extracted, single endonuclease digestion is carried out with inscribe BglII, obtains line
Property carrier.Its reaction system is as follows: 5ul FD buffer (is purchased from Thermol, article No.: FD0083), 2.5ul BglII (purchase
From Thermol, article No.: FD0083), 2.5ul fastAP (dephosphorylation) (is purchased from Thermol, article No.: EF0651),
PFC330-BEC plasmid 40ul (includes 10ug Plasmid DNA), and 37 DEG C are reacted 8 hours, obtains linearisation pFC330-BEC carrier.
5, using DNA fragmentation connection kit (DNA Ligation Kit Ver 2.1, article No.: 6022) will linearisation
PFC330-BEC carrier and the fwnA-sgRNA containing BglII cohesive end connect into a cyclic plasmid pFC330-BEC-
fwnAsgRNA.Connection product converts Escherichia coli MatchI TI (being purchased from Takara company) competence, chooses after 37 DEG C of culture 12h
Take transformant under the conditions of liquid LB+Amp (100 μ g/ml of final concentration) culture medium, 37 DEG C, shaking speed is 200rpm culture
12h, is bacterium solution PCR, and preliminary screening goes out positive transformant.Positive transformant upgrading grain that bacterium solution PCR is screened, digestion verification,
It selects that 2 plasmid sizes are correct and the correct positive transformant of digestion verification, is sequenced.Take after sequencing result with template
Sequence compares, and obtains correct pFC330-BEC-fwnAsgRNA base editor's carrier.
6, expression of the fwnA gene base editor carrier in aspergillus niger FGSC1279: according to (Gomi K, Iimura Y,
Hara S.Integrative transformation of Aspergillus oryzae with a plasmid
containing the Aspergillus nidulans argB gene[J].Agricultural and biological
Chemistry, 1987,51 (9): 2549-2555.) in provide the step of prepare host strain aspergillus niger FGSC1279 (Δ ku Δ
Base editor carrier pFC330-BEC-fwnAsgRNA plasmid obtained above is transformed into plasm by protoplast pyrG)
In body, hypertonic CD culture medium is coated with (comprising 1M sucrose, 0.3% (w/v) NaNO3, 0.2% (w/v) KCl, 0.05% (w/v)
MgSO4.7H2O, 0.1% (w/v) K2HPO4.3H2O, 0.001% (w/v) FeSO4.7H2O, 2% (w/v) agar powder, pH 5.5,
The unit of w/v is g/mL), 30 DEG C of incubators are put into, observe transformant growing state after 3d.
7, it aspergillus niger transformant target site PCR and Sanger sequencing: after above-mentioned transformant is grown on hypertonic CD plate, chooses
It (include 2% (w/v) glucose, 0.3% (w/v) NaNO to new common CD solid plate3, 0.2% (w/v) KCl, 0.05% (w/
v)MgSO4.7H2O, 0.1% (w/v) K2HPO4.3H2O, 0.001% (w/v) FeSO4.7H2O, 2% (w/v) agar powder, pH
5.5, w/v unit is g/mL), it is put into 30 DEG C of incubator culture 3d and grows up to bacterium colony, after bacterium colony is grown up, extract conversion subbase
Because of group, fwnA Gene Partial is expanded as pcr template.Design fwnA partial sequence amplimer;Wherein,
Forward primer fwnA-BE-F:
5'-TGTCGCCTCGGGAAGCACTC-3';
Reverse primer fwnA-BE-R:
5'-AATACCAGGAGCCGTTGAGG-3'。
In Guangzhou, Tian Yihuiyuan Biotechnology Co., Ltd synthesizes above-mentioned two primers, and expands fwnA according to the procedure below
Partial sequence:
98℃5min;98 DEG C of 30s, 60 DEG C of 30s, 72 DEG C of 1min15s;Totally 30 recycle, then 72 DEG C of 5min;Last 25
DEG C, 1s;Amplified production is the identification of 1% agarose gel electrophoresis through mass fraction, with PCR product QIAquick Gel Extraction Kit recovery purifying
PCR product, and PCR product is sent to Guangzhou Tian Yihuiyuan Biotechnology Co., Ltd sequence verification.
Experimental result discovery has 21 transformants that cytimidine occurs to thymidine in 31 transformants of selection
Base mutation, wherein 18 occur No. 6 and No. 7 double mutation, 3 occur No. 7 single mutation, sequencing result and phenotype such as Fig. 3
It is shown.
A kind of system (the application side of pFC330-BEC plasmid of fixed point editor filamentous fungi genome provided by the invention
Method), using BE3 filamentous fungi expression vector, (expression is by nCas9 (D10A), deaminase (rAPOBEC1) and ura DNA glycosyl
Change the fusion protein that enzyme inhibits albumen (UGI) composition, gene editing is carried out to filamentous fungi.Above-described embodiment is with aspergillus niger prtT
It is that target gene verifies the system with fwnA, the results showed that, in two selected target genes, it is prominent to obtain expected fixed point
Become transformant, accurate base point mutation is realized in aspergillus niger, to reach the effect of amino acid mutation or gene inactivation
Fruit.
Above embodiments are only preferrred embodiment of the present invention, for explaining only the invention, are not intended to limit the present invention, this
Field technical staff should belong to guarantor of the invention without departing from change made under spirit of the invention, replacement, modification etc.
Protect range.
Sequence table
<110>South China Science & Engineering University
<120>a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base and its application
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 735
<212> DNA
<213>artificial synthesized (artificial sequence)
<400> 1
atgagcagcg aaaccggtcc tgtggctgtg gaccctaccc tccgccgtcg gatcgagcct 60
cacgagttcg aagtcttctt cgatccgcgt gagctgcgga aggaaacctg cctgctctac 120
gaaatcaact ggggcggtcg ccacagcatc tggcgtcata cctcccagaa caccaacaag 180
catgtcgagg tgaacttcat cgaaaaattc accaccgagc ggtacttctg ccccaacacc 240
cgctgctcca tcacctggtt cctcagctgg tccccttgcg gtgaatgcag ccgcgctatc 300
accgagttcc tgtcccgtta cccgcacgtg accctcttca tctacatcgc tcggctgtac 360
caccatgctg accccaggaa caggcaaggt ctgagggatc tcatcagctc cggtgtcacc 420
atccagatca tgaccgagca agaatccggc tactgctggc gtaacttcgt gaactacagc 480
ccttccaacg aagcccactg gcctcgttac ccgcatctgt gggtccggct ctacgtgctg 540
gagctctact gcatcatcct gggtctgcct ccctgcctga acatcctccg ccgtaagcag 600
ccccaactca ccttcttcac catcgccctc cagagctgcc actaccaacg cctgccgccc 660
catatcctct gggctaccgg cctgaaaagc ggttccgaga ccccgggcac cagcgaatcc 720
gccacccccg agtcc 735
<210> 2
<211> 297
<212> DNA
<213>artificial synthesized (artificial sequence)
<400> 2
agcggcggtt ccaccaacct gagcgacatc atcgagaaag aaaccggcaa gcagctcgtc 60
atccaagagt ccatcctgat gctcccggag gaagtcgagg aagtgatcgg taacaaaccc 120
gaaagcgaca tcctggtcca caccgcctac gacgagagca ccgatgaaaa cgtgatgctg 180
ctcacctccg acgcccccga gtacaaacct tgggctctgg tcatccagga ttccaacggc 240
gaaaacaaaa tcaagatgct cagcggcggt tcccccaaga aaaagcgcaa ggtgtag 297
<210> 3
<211> 16766
<212> DNA
<213>artificial synthesized (artificial sequence)
<400> 3
accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 60
ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 120
gcgctgcgat gataccgcga gaaccacgct caccggctcc ggatttatca gcaataaacc 180
agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 240
ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 300
ttgttgccat cgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 360
gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 420
ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 480
tggttatggc agcgctacat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 540
tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 600
cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 660
tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 720
gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 780
tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 840
ggaaatgttg aatactcata ttcttccttt ttcaatatta ttgaagcatt tatcagggtt 900
attgtctcat gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggtca 960
gtgttacaac caattaacca attctgaaca ttatcgcgag cccatttata cctgaatatg 1020
gctcataaca ccccttgttt gcctggcggc agtagcgcgg tggtcccacc tgaccccatg 1080
ccgaactcag aagtgaaacg ccgtagcgcc gatggtagtg tggggactcc ccatgcgaga 1140
gtagggaact gccaggcatc aaataaaacg aaaggctcag tcgaaagact gggcctttcg 1200
cccgggctaa ttatggggtg tcgcccttat tcgactctat agtgaagttc ctattctcta 1260
gaaagtatag gaacttctga agtggggatt taaatgcggc cgcgctgagg gtttaatcga 1320
cgaagcagct gacggccagt gccaagctta acgcgtaccc gggcccagta tatgttccgc 1380
agatgactgg agctctgcca tacgtgccct ctcaagcacc atttgttcca tctacagaga 1440
ctagtcacca actagtctat caagactcac agggtacatt gctgagacca actgaccaga 1500
ggcagggtag cggattgacg gctccatctc cttcacttac aaggtctatt gaaagccctt 1560
tagcatcacc aagcggagaa tagattgtta agcttatttt ttgtatactg ttttgtgata 1620
gcacgaagtt tttccacggt atcttgtaaa aatatatatt tgtggcgggc ttacctacat 1680
caaattaata agagactaat tataaactaa acacacaagc aagctacttt agggtaaaag 1740
tttataaatg cttttgacgt ataaacgttg cttgtattta ttattacaat taaaggtgga 1800
tagaaaacct agagactagt tagaaactaa tctcaggttt gcgttaaact aaatcagagc 1860
ccgagaggtt aacagaacct agaaggggac tagatatccg ggtagggaaa caaaaaaaaa 1920
aaacaagaca gccacatatt agggagacta gttagaagct agttccagga ctaggaaaat 1980
aaaagacaat gataccacag tctagttgac aactagatag attctagatt gaggccaaag 2040
tctctgagat ccaggttagt tgcaactaat actagttagt atctagtctc ctataactct 2100
gaagctagaa taacttacta ctattatcct caccactgtt cagctgcgca aacggagtga 2160
ttgcaaggtg ttcagagact agttattgac tagtcagtga ctagcaataa ctaacaaggt 2220
attaacctac catgtctgcc atcaccctgc acttcctcgg gctcagcagc cttttcctcc 2280
tcattttcat gctcattttc cttgtttaag actgtgacta gtcaaagact agtccagaac 2340
cacaaaggag aaatgtctta ccactttctt cattgcttgt ctcttttgca ttatccatgt 2400
ctgcaactag ttagagtcta gttagtgact agtccgacga ggacttgctt gtctccggat 2460
tgttggagga actctccagg gcctcaagat ccacaacaga gccttctaga agactggtca 2520
ataactagtt ggtctttgtc tgagtctgac ttacgaggtt gcatactcgc tccctttgcc 2580
tcgtcaatcg atgagaaaaa gcgccaaaac tcgcaatatg gctttgaacc acacggtgct 2640
gagactagtt agaatctagt cccaaactag cttggatagc ttacctttgc cctttgcgtt 2700
gcgacaggtc ttgcagggta tggttccttt ctcaccagct gatttagctg ccttgctacc 2760
ctcacggcgg atctgccata aagagtggct agaggttata aattagcact gatcctaggt 2820
acggggctga atgtaacttg cctttccttt ctcatcgcgc ggcaagacag gcttgctcaa 2880
attcctacca gtcacagggg tatgcacggc gtacggacca cttgaactag tcacagatta 2940
gttagcaact agtctgcatt gaatggctgt acttacgggc cctcgccatt gtcctgatca 3000
tttccagctt caccctcgtt gctgcaaagt agttagtgac tagtcaagga ctagttgaaa 3060
tgggagaaga aactcacgaa ttctcgactc ccttagtatt gtggtccttg gacttggtgc 3120
tgctatatat tagctaatac actagttaga ctcacagaaa cttacgcagc tcgcttgcgc 3180
ttcttggtag gagtcggggt tgggagaaca gtgccttcaa acaagccttc ataccatgct 3240
acttgactag tcagggacta gtcaccaagt aatctagata ggacttgcct ttggcctcca 3300
tcagttcctt catagtggga ggaccattgt gcaatgtaaa ctccatgccg tgggagttct 3360
tgtccttcaa gtgcttgacc aatatgtttc tgttggcaga gggaacctgt caactagtta 3420
ataactagtc agaaactatg atagcagtag actcactgta cgcttgaggc atcccttcac 3480
tcggcagtag acttcatatg gatggatatc aggcacgcca ttgtcgtcct gtggactagt 3540
cagtaactag gcttaaagct agtcgggtcg gcttactatc ttgaaatccg gcagcgtaag 3600
ctccccgtcc ttaactgcct cgagatagtg acagtactct ggggactttc ggagatcgtt 3660
atcgttatcg cgaatgctcg gcatactaac tgttgactag tcttggacta gtcccgagca 3720
aaaaggattg gaggaggagg aggaaggtga gagtgagaca aagagcgaaa taagagcttc 3780
aaaggctatc tctaagcagt atgaaggtta agtatctagt tcttgactag atttaaagag 3840
atttcgacta gttatgtacc tggagtttgg atataggaat gtgttgtggt aacgaaatgt 3900
aagggggagg aaagaaaaag tcgtcaagag gtaactctaa gtcggccatt cctttttggg 3960
aggcgctaac cataaacggc atggtcgact tagagttagc tcagggaatt tagggagtta 4020
tctgcgacca ccgaggaacg gcggaatgcc aaagaatccc gatggagctc tagctggcgg 4080
ttgacaaccc caccttttgg cgtttctgcg gcgttgcagg cgggactgga tacttcgtag 4140
aaccagaaag gcaaggcaga acgcgctcag caagagtgtt ggaagtgata gcatgatgtg 4200
ccttgttaac taggtaccaa tctgcagtat gcttgatgtt atccaaagtg tgagagagga 4260
aggtccaaac atacacgatt gggagagggc ctaggtataa gagtttttga gtagaacgca 4320
tgtgagccca gccatctcga ggagattaaa cacgggccgg catttgatgg ctatgttagt 4380
accccaatgg aaacggtgag agtccagtgg tcgcagataa ctccctaaat tccctgagct 4440
aactctaagt cgaccatgcc gtttatggtt agcgcctccc aaaaaggaat ggccgactta 4500
gagttacctc ttgacgactt tttctttcct cccccttaca tttcgttacc acaacacatt 4560
cctatatcca aactccaggt acataactag tcgaaatctc tttaaatcta gtcaagaact 4620
agatacttaa ccttcatact gcttagagat agcctttgaa gctcttattt cgctctttgt 4680
ctcactctca ccttcctcct cctcctccaa tcctttttgc tcgggactag tccaagacta 4740
gtcaacagtt agtatgccga gcattcgcga taacgataac gatctccgaa agtccccaga 4800
gtactgtcac tatctcgagg cagttaagga cggggagctt acgctgccgg atttcaagat 4860
agtaagccga cccgactagc tttaagccta gttactgact agtccacagg acgacaatgg 4920
cgtgcctgat atccatccat atgaagtcta ctgccgagtg aagggatgcc tcaagcgtac 4980
agtgagtcta ctgctatcat agtttctgac tagttattaa ctagttgaca ggttccctct 5040
gccaacagaa acatattggt caagcacttg aaggacaaga actcccacgg catggagttt 5100
acattgcaca atggtcctcc cactatgaag gaactgatgg aggccaaagg caagtcctat 5160
ctagattact tggtgactag tccctgacta gtcaagtagc atggtatgaa ggcttgtttg 5220
aaggcactgt tctcccaacc ccgactccta ccaagaagcg caagcgagct gcgtaagttt 5280
ctgtgagtct aactagtgta ttagctaata tatagcagca ccaagtccaa ggaccacaat 5340
actaagggag tcgagaattc gtgagtttct tctcccattt caactagtcc ttgactagtc 5400
actaactact ttgcagcaac gagggtgaag ctggaaatga tcaggacaat ggcgagggcc 5460
cgtaagtaca gccattcaat gcagactagt tgctaactaa tctgtgacta gttcaagtgg 5520
tccgtacgcc gtgcataccc ctgtgactgg taggaatttg agcaagcctg tcttgccgcg 5580
cgatgagaaa ggaaaggcaa gttacattca gccccgtacc taggatcagt gctaatttat 5640
aacctctagc cactctttat ggcagatccg ccgtgagggt agcaaggcag ctaaatcagc 5700
tggtgagaaa ggaaccatac cctgcaagac ctgtcgcaac gcaaagggca aaggtaagct 5760
atccaagcta gtttgggact agattctaac tagtctcagc accgtgtggt tcaaagccat 5820
attgcgagtt ttggcgcttt ttctcatcga ttgacgaggc aaagggagcg agtatgcaac 5880
ctcgtaagtc agactcagac aaagaccaac tagttattga ccagtcttct agaaggctct 5940
gttgtggatc ttgaggccct ggagagttcc tccaacaatc cggagacaag caagtcctcg 6000
tcggactagt cactaactag actctaacta gttgcagaca tggataatgc aaaagagaca 6060
agcaatgaag aaagtggtaa gacatttctc ctttgtggtt ctggactagt ctttgactag 6120
tcacagtctt aaacaaggaa aatgagcatg aaaatgagga ggaaaaggct gctgagcccg 6180
aggaagtgca gggtgatggc agacatggta ggttaatacc ttgttagtta ttgctagtca 6240
ctgactagtc aataactagt ctctgaacac cttgcaatca ctccgtttgc gcagctgaac 6300
agtggtgagg ataatagtag taagttattc tagcttcaga gttataggag actagatact 6360
aactagtatt agttgcaact aacctggatc tcagagactt tggcctcaat ctagaatcta 6420
tctagttgtc aactagactg tggtatcatt gtcttttatt ttcctagtcc tggaactagc 6480
ttctaactag tctccctaat atgtggctgt cttgtttttt ttttttgttt ccctacccgg 6540
atatctagtc cccttctagg ttctgttaac ctctcgggct ctgatttagt ttaacgcaaa 6600
cctgagatta gtttctaact agtctctagg ttttctatcc acctttaatt gtaataataa 6660
atacaagcaa cgtttatacg tcaaaagcat ttataaactt ttaccctaaa gtagcttgct 6720
tgtgtgttta gtttataatt agtctcttat taatttgatg taggtaagcc cgccacaaat 6780
atatattttt acaagatacc gtggaaaaac ttcgtgctat cacaaaacag tatacaaaaa 6840
ataagcttaa caatctattc tccgcttggt gatgctaaag ggctttcaat agaccttgta 6900
agtgaaggag atggagccgt caatccgcta ccctgcctct ggtcagttgg tctcagcaat 6960
gtaccctgtg agtcttgata gactagttgg tgactagtct ctgtagatgg aacaaatggt 7020
gcttgagagg gcacgtatgg cagagctcca gtcatctgcg gaacatatac tgggcccggg 7080
aagatctcat ggtcatagct gtttccgctg agggtttaat taagacctca gccgagacag 7140
cagaatcacc gcccaagtta agcctttgtg ctgatcatgc tctcgaacgg gccaagttcg 7200
ggaaaagcaa aggagcgttt agtgaggggc aatttgactc acctcccagg caacagatga 7260
ggggggcaaa aagaaagaaa ttttcgtgag tcaatatgga ttccgagcat cattttcttg 7320
cggtctatct tgctacgtat gttgatcttg acgctgtgga tcaagcaacg ccactcgctc 7380
gctccatcgc aggctggtcg cagacaaatt aaaaggcggc aaactcgtac agccgcgggg 7440
ttgtccgctg caaagtacag agtgataaaa gccgccatgc gaccatcaac gcgttgatgc 7500
ccagcttttt cgatccgaga atccaccgta gaggcgatag caagtaaaga aaagctaaac 7560
aaaaaaaaat ttctgcccct aagccatgaa aacgagatgg ggtggagcag aaccaaggaa 7620
agagtcgcgc tgggctgccg ttccggaagg tgttgtaaag gctcgacgcc caaggtggga 7680
gtctaggaga agaatttgca tcgggagtgg ggcgggttac ccctccatat ccaatgacag 7740
atatctacca gccaagggtt tgagcccgcc cgcttagtcg tcgtcctcgc ttgcccctcc 7800
ataaaaggat ttcccctccc cctcccacaa aattttcttt cccttcctct ccttgtccgc 7860
ttcagtacgt atatcttccc ttccctcgct tctctcctcc atccttcttt catccatctc 7920
ctgctaactt ctctgctcag cacctctacg cattactagc cgtagtatct gagcacttct 7980
cccttttata ttccacaaaa cataacacaa ccttcaccat gagcagcgaa accggtcctg 8040
tggctgtgga ccctaccctc cgccgtcgga tcgagcctca cgagttcgaa gtcttcttcg 8100
atccgcgtga gctgcggaag gaaacctgcc tgctctacga aatcaactgg ggcggtcgcc 8160
acagcatctg gcgtcatacc tcccagaaca ccaacaagca tgtcgaggtg aacttcatcg 8220
aaaaattcac caccgagcgg tacttctgcc ccaacacccg ctgctccatc acctggttcc 8280
tcagctggtc cccttgcggt gaatgcagcc gcgctatcac cgagttcctg tcccgttacc 8340
cgcacgtgac cctcttcatc tacatcgctc ggctgtacca ccatgctgac cccaggaaca 8400
ggcaaggtct gagggatctc atcagctccg gtgtcaccat ccagatcatg accgagcaag 8460
aatccggcta ctgctggcgt aacttcgtga actacagccc ttccaacgaa gcccactggc 8520
ctcgttaccc gcatctgtgg gtccggctct acgtgctgga gctctactgc atcatcctgg 8580
gtctgcctcc ctgcctgaac atcctccgcc gtaagcagcc ccaactcacc ttcttcacca 8640
tcgccctcca gagctgccac taccaacgcc tgccgcccca tatcctctgg gctaccggcc 8700
tgaaaagcgg ttccgagacc ccgggcacca gcgaatccgc cacccccgag tccgacaaga 8760
agtatagcat cgggctggct attggaacga actcggttgg ttgggctgtg attacggacg 8820
aatacaaggt gccatccaag aagtttaagg tcctgggaaa caccgaccgt cactcaatca 8880
agaagaatct cattggagcc ctgctcttcg atagtgggga gaccgccgaa gctactcgac 8940
tgaagcgaac ggctcgccgg cgttatacac gacgcaagaa tcgcatctgc tacctccagg 9000
agattttcag caacgaaatg gctaaggttg atgactcatt ctttcatcga ctcgaagaaa 9060
gtttcttggt cgaggaggat aagaagcacg agcgccatcc gatctttggt aacattgtgg 9120
atgaggttgc ctatcacgaa aagtacccaa ctatctatca tcttcgtaag aagctggtcg 9180
atagcacgga caaggctgat ttgcgactta tctacctggc actcgcgcac atgattaagt 9240
tccgcggcca ttttcttatc gagggtgacc tgaaccccga taattctgac gttgataagc 9300
tcttcatcca gttggtccaa acctacaatc agctgtttga ggaaaaccct attaatgcat 9360
ctggcgtgga cgccaaggct atcctttcgg cgcgcctgtc taagtcgcgg cgtttggaga 9420
accttatcgc acaactcccc ggcgaaaaga agaacggcct cttcggtaat ttgattgcgt 9480
tgtcacttgg tctgactcct aacttcaaga gtaattttga cctggcagag gatgcgaagc 9540
tccagttgtc taaggatacg tatgatgacg atctcgacaa cttgcttgcc caaatcggtg 9600
accagtacgc tgatcttttc ctggccgcta agaatctctc agatgcaatc ctgctcagtg 9660
acattttgcg ggtcaacacc gagattacta aggcccccct gtcagctagt atgatcaagc 9720
ggtatgatga gcaccatcag gacctcacct tgcttaaggc cctcgtgcgt cagcaattgc 9780
ctgagaagta caaggaaatc ttctttgacc aatccaagaa cggatacgca gggtatattg 9840
atggcggtgc gagccaggag gaattctaca agtttatcaa gccgattttg gagaagatgg 9900
acggcactga ggaactgctc gtcaagctga atcgcgaaga tttgcttcgt aagcaacgaa 9960
cgttcgacaa cggctccatc ccgcaccaga ttcatctggg cgagctccac gccatccttc 10020
gacgccagga agatttctac ccatttctga aggacaaccg tgagaagatc gaaaagattc 10080
ttacattccg aatcccctac tatgtgggac ctttggcccg tgggaattcc cgatttgctt 10140
ggatgacccg aaagagcgag gaaaccatca ctccgtggaa cttcgaggaa gtcgtggaca 10200
agggtgcatc cgcgcagagc ttcattgagc ggatgaccaa ttttgataag aaccttccga 10260
atgaaaaggt cctgccaaag cattcgctgc tctacgagta tttcaccgtg tataacgaac 10320
tgactaaggt caagtacgtg acggagggaa tgcggaagcc agccttcctc tcaggggaac 10380
aaaagaaggc tatcgtcgat ttgcttttta agaccaatcg taaagtgact gttaagcagc 10440
tgaaggagga ttatttcaag aagattgaat gtttcgactc cgtcgagatc agcggcgtgg 10500
aagatcgctt taacgcttcc ctcggtacct accacgacct gctcaagatc attaaggaca 10560
aggatttcct cgataacgag gaaaatgagg acatcttgga agatattgtc ctcacgttga 10620
cactttttga ggaccgcgaa atgatcgagg aacggctcaa gacatatgcc catttgttcg 10680
acgataaggt gatgaagcag ctgaagcggc gtcgatacac cggatggggt cgccttagcc 10740
ggaagctgat caacggcatt cgagataagc aatctggtaa gactatcttg gatttcctta 10800
agtcggacgg cttcgccaac cgcaatttta tgcagcttat tcacgacgat tccctgacgt 10860
tcaaggagga catccagaag gcacaagtct caggacaagg ggattccctg cacgagcata 10920
tcgccaacct ggctggatcc ccggcgatca agaaggggat tcttcagacc gtcaaggttg 10980
tcgacgagct ggtcaaggtg atgggccgtc ataagccaga aaacatcgtg attgagatgg 11040
cccgagaaaa tcagaccact caaaagggtc agaagaacag ccgcgagcgg atgaagcgga 11100
tcgaggaagg cattaaggaa cttggttctc agatcctgaa ggagcaccct gttgaaaaca 11160
cacagctcca aaatgagaag ctgtatctct actatttgca aaatggacgc gacatgtacg 11220
tcgatcagga gctcgacatt aaccggttgt cggactacga tgttgaccat atcgtcccgc 11280
aatccttcct taaggacgat agcattgata acaaggtgct gactcgctca gataagaacc 11340
ggggcaagtc cgacaatgtt ccaagcgagg aagtggttaa gaagatgaag aactactggc 11400
gccaattgct taatgccaag ctcatcacac agcgcaagtt tgacaacttg accaaggccg 11460
agcggggagg gctgagtgaa ctcgataagg ctggcttcat caagcgtcaa ctcgtggaga 11520
cgcgacagat cacaaagcac gttgctcaga ttctggactc ccggatgaac acaaagtacg 11580
acgagaatga taagctcatc cgtgaagtta aggtcattac cctcaagtct aagttggtgt 11640
cggatttccg caaggacttc caattttata aggttcggga gatcaacaat tatcaccatg 11700
cacatgatgc gtacctcaac gcagtcgtgg gaactgcgct catcaagaag tatcccaagt 11760
tggagtccga attcgtctac ggggattata aggtttacga cgtccgcaag atgatcgcca 11820
agagtgagca ggaaattggc aaggccacgg ctaagtattt cttttactcc aacatcatga 11880
atttctttaa gacggagatc acactcgcca atggagaaat ccgtaagcga cctttgattg 11940
agaccaacgg cgagactggt gaaatcgttt gggataaggg gcgcgacttc gctaccgtgc 12000
ggaaggttct gagcatgccg caagtcaata tcgtcaagaa aaccgaggtg cagacaggcg 12060
gtttctctaa ggaatcgatt cttccaaagc gtaactctga caagctgatc gctcgaaaga 12120
aggattggga ccccaagaag tatggagggt tcgattctcc tacagtggca tactcggttc 12180
tcgttgtcgc gaaggttgag aagggaaagt ctaagaagct gaagtcggtc aaggaactgc 12240
tcgggatcac cattatggag cgctccagct tcgaaaagaa tcccatcgac tttctcgagg 12300
ccaagggcta taaggaagtc aagaaggatc ttatcattaa gctgcctaag tactctttgt 12360
tcgagcttga aaacggtcga aagcgaatgc tcgcatcggc aggagagttg cagaagggga 12420
atgaattggc acttccctca aagtacgtga acttcctgta tctcgcgtcc cactacgaga 12480
agctgaaggg tagccctgag gacaacgaac agaagcaact ttttgttgag caacacaagc 12540
attatctgga tgagatcatt gaacagattt cagagttcag taagcgcgtc atcctcgccg 12600
atgctaatct cgacaaggtg ttgtcggcct acaacaagca ccgtgacaag ccgatccgag 12660
agcaggctga aaatatcatt catctgttca ccctcactaa cttgggagca ccagcagcgt 12720
tcaagtattt tgatacgaca atcgaccgta agcgatacac gtccacaaag gaggtgcttg 12780
atgcgaccct gattcatcaa tccatcactg ggctctatga aacccgtatc gaccttagtc 12840
aactgggggg cgacagcggc ggttccacca acctgagcga catcatcgag aaagaaaccg 12900
gcaagcagct cgtcatccaa gagtccatcc tgatgctccc ggaggaagtc gaggaagtga 12960
tcggtaacaa acccgaaagc gacatcctgg tccacaccgc ctacgacgag agcaccgatg 13020
aaaacgtgat gctgctcacc tccgacgccc ccgagtacaa accttgggct ctggtcatcc 13080
aggattccaa cggcgaaaac aaaatcaaga tgctcagcgg cggttccccc aagaaaaagc 13140
gcaaggtgta ggcggacatt cgatttatgc cgttatgact tccttaaaaa agcctttacg 13200
aatgaaagaa atggaattag acttgttatg tagttgattc tacaatggat tatgattcct 13260
gaacttcaaa tccgctgttc attattaatc tcagctcttc ccgtaaagcc aatgttgaaa 13320
ctattcgtaa atgtacctcg ttttgcgtgt accttgctta tcacgtgata ttacatgacc 13380
tggacagagt tctgcgcgaa agtcataacg taaatcccgg gcggtaggtg cgtcccgggc 13440
ggaaggtagt tttctcgtcc accccaacgc gtttatcaac ctcaactttc aacaaccatc 13500
atgccaccaa aagcgcgtaa aacaaagcga gatttgattg agcaagaggg caggatccaa 13560
tgcgcgattc aagacattaa aaatggaaaa tttcaaaaaa ttgcgcccgc agcgcgtgca 13620
tacaaaattc atcccaatac aagtgtaatt cctcgtgtac tgtgtaagcg cccactaggt 13680
aatatgacat gattacgaat tcgagctcgg tacccggccg gaactccacg tctagaggat 13740
ccaccagtga ttgaccaatg ttttatcttc tacagttctg cctgtctacc ccattctagc 13800
tgtacctgac tacagagtag tttaattgtg gttgacccca cagtcggagg cggaggaata 13860
cagcaccgat gtggcctgtc tccatccaga ttggcacgca atttttacac gcggaaaaga 13920
tcgagataga gtacgacttt aaatttagtc cccggcggct tctattttag aatatttgag 13980
atttgattct caagcaattg atttggttgg gtcaccctca attggataat atacctcatt 14040
gctcggctac ttcaactcat caatcaccgt cataccccgc atataaccct ccattcccac 14100
gatgtcgtcc aagtcgcaat tgacttacgg tgctcgagcc agcaagcacc ccaatcctct 14160
ggcaaagaga ctttttgaga ttgccgaagc aaagaagaca aacgttaccg tctctgctga 14220
tgtgacgaca acccgagaac tcctggacct cgctgaccgt acggaagctg ttggatccaa 14280
tacatatgcc gtctagcaat ggactaatca acttttgatg atacaggtct cggtccctac 14340
atcgccgtca tcaagacaca catcgacatc ctcaccgatt tcagcgtcga cactatcaat 14400
ggcctgaatg tgctggctca aaagtacaac tttttgatct tcgaggaccg caaattcatc 14460
gacatcggca ataccgtcca gaagcaatac cacggcggtg ctctgaggat ctccgaatgg 14520
gcccacatta tcaactgcag cgttctccct ggcgagggca tcgtcgaggc tctggcccag 14580
accgcatctg cgcaagactt cccctatggt cctgagagag gactgttggt cctggcagag 14640
atgaccccca aaggatcgct ggctacgggc gagtatacca aggcatcggt tgactacgct 14700
cgcaaataca agaacttcgt tatgggtttc gtgtcgacgc gggccctgac ggaagtgcag 14760
tcggatgtgt cttcagcctc ggaggatgaa gatttcgtgg tcttcacgac gggtgtgaac 14820
ctctcttcca aaggagataa gcttggacag caataccaga ctcctgcatc ggctattgga 14880
cgcggtgccg actttatcat cgccggtcga ggcatctacg ctgctcccga cccggttgaa 14940
gctgcacagc ggtaccagaa agaaggctgg gaagcttata tggccagagt atgcggcaag 15000
tcatgatttc ctcttggagc aaaagtgtag tgccagtacg agtgttgtgg aggaaggctg 15060
catacattgt gcctgtcatt aaacgatgag ctcgtccgta ttggcccctg taatgccatg 15120
ttttccgccc ccaatcgtca aggttttccc tttgttagat tcctaccagt catctagcaa 15180
ggcggccgca gctagcacaa ttgaggcatc cccactaccg cattaagacc tcagcgcggc 15240
cgcaaattta aataaaatga agtgaagttc ctatactttc tagagaatag gaacttctat 15300
agtgagtcga ataagggcga cacaaaattt attctaaatg cataataaat actgataaca 15360
tcttatagtt tgtattatat tttgtattat cgttgacatg tataattttg atatcaaaaa 15420
ctgattttcc ctttattatt ttcgagattt attttcttaa ttctctttaa caaactagaa 15480
atattgtata tacaaaaaat cataaataat agatgaatag tttaattata ggtgttcatc 15540
aatcgaaaaa gcaacgtatc ttatttaaag tgcgttgctt ttttctcatt tataaggtta 15600
aataattctc atatatcaag caaagtgaca ggcgccctta aatattctga caaatgctct 15660
ttccctaaac tccccccata aaaaaacccg ccgaagcggg tttttacgtt atttgcggat 15720
taacgattac tcgttatcag aaccgcccag ggggcccgag cttaagactg gccgtcgttt 15780
tacaacacag aaagagtttg tagaaacgca aaaaggccat ccgtcagggg ccttctgctt 15840
agtttgatgc ctggcagttc cctactctcg ccttccgctt cctcgctcac tgactcgctg 15900
cgctcggtcg ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta 15960
tccacagaat caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc 16020
aggaaccgta aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag 16080
catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac 16140
caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc 16200
ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcatag ctcacgctgt 16260
aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc 16320
gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga 16380
cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta 16440
ggcggtgcta cagagttctt gaagtggtgg gctaactacg gctacactag aagaacagta 16500
tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga 16560
tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca gcagattacg 16620
cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc tgacgctcag 16680
tggaacgacg cgcgcgtaac tcacgttaag ggattttggt catgagcttg cgccgtcccg 16740
tcaagtcagc gtaatgctct gctttt 16766
<210> 4
<211> 635
<212> DNA
<213>artificial synthesized (artificial sequence)
<400> 4
gcaggcggtt gcaagcgatc tatcgtgaat ttgtggaggg acgtaatggt gaaatgccga 60
atggcgaagc aggtcgggag atcggtggtc ggacgagcct gatgtagatg ggtgcatatc 120
tttcttttct ctttcacaat ttcaagatca tgtattagaa ctacattgct atgtttcagc 180
aatatatatg catagctaga gagcgatgtt acgatgagac atgtaatctt tgaacatttc 240
tctgtacagc ttgtcagagt ttcgaaggtt aagctcgaga gcaaggaggg gaaaagaaga 300
caaaaaagac actcggtccg gtctcgaacc gacgaccttt cgcacacacg tagaaggtac 360
agaaactcaa cacctccaaa agaggtctgt aagaatgaaa gtttgaccaa aagcatcatc 420
agttttagag ctagaaatag caagttaaaa taaggctagt ccgttatcaa cttgaaaaag 480
tggcaccgag tcggtgcttt ttttttgagc atttatcagc ttgatataga ggtaggaatg 540
tatggaggtg cagaatggct attttgttat tggagcgggt tcgaaacgga gggcaggaga 600
ctttttctaa atacgtcacg tgatatagag ctgct 635
<210> 5
<211> 632
<212> DNA
<213>artificial synthesized (artificial sequence)
<400> 5
gcaggcggtt gcaagcgatc tatcgtgaat ttgtggaggg acgtaatggt gaaatgccga 60
atggcgaagc aggtcgggag atcggtggtc ggacgagcct gatgtagatg ggtgcatatc 120
tttcttttct ctttcacaat ttcaagatca tgtattagaa ctacattgct atgtttcagc 180
aatatatatg catagctaga gagcgatgtt acgatgagac atgtaatctt tgaacatttc 240
tctgtacagc ttgtcagagt ttcgaaggtt aagctcgaga gcaaggaggg gaaaagaaga 300
caaaaaagac actcggtccg gtctcgaacc gacgaccttt cgcacacacg tagaaggtac 360
agaaactcaa cacctccaaa agaggtctgt aagaatgaaa ggtaaccgag catttacgcc 420
gttttagagc tagaaatagc aagttaaaat aaggctagtc cgttatcaac ttgaaaaagt 480
ggcaccgagt cggtgctttt tttttgagca tttatcagct tgatatagag gtaggaatgt 540
atggaggtgc agaatggcta ttttgttatt ggagcgggtt cgaaacggag ggcaggagac 600
tttttctaaa tacgtcacgt gatatagagc tg 632
Claims (10)
1. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base, which is characterized in that nucleotide sequence such as SEQ ID
Shown in NO:3.
2. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 1, which is characterized in that
Include the rAPOBEC1-XTEN-nCas9-UGI fusion segment that can be expressed in aspergillus niger.
3. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 1, which is characterized in that
Promoter comprising E. coli resistance genetic fragment AmpR and rAPOBEC1-XTEN-nCas9-UGI expressing fusion protein
Ptef。
4. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 2, which is characterized in that
The rAPOBEC1-XTEN-nCas9-UGI fusion segment includes rAPOBEC1-XTEN genetic fragment and UGI gene piece
Section.
5. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 4, which is characterized in that
The nucleotide sequence of the rAPOBEC1-XTEN genetic fragment is as shown in SEQ ID NO:1, the nucleosides of the UGI genetic fragment
Acid sequence is as shown in SEQ ID NO:2;It is close that the rAPOBEC1-XTEN genetic fragment and UGI genetic fragment pass through aspergillus niger
Numeral optimization, can in aspergillus niger normal expression.
6. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 1, which is characterized in that
Include the plasmid replication origin ori that can be used to be inserted into the site BglII and Escherichia coli of sgRNA segment.
7. a kind of pFC330-BEC plasmid for being able to achieve the accurate point mutation of base according to claim 1, which is characterized in that
Comprising pyrG selection markers and it can be realized the filamentous fungi autonomously replicating sequence AMA1 of mark cycle.
8. be able to achieve described in claim any one of 1-7 the pFC330-BEC plasmid of the accurate point mutation of base in filamentous fungi into
The application of row base editor.
9. application according to claim 8, which is characterized in that the filamentous fungi includes aspergillus niger.
10. application according to claim 8, which is characterized in that the base editor includes that sport thymus gland phonetic for cytimidine
The editor of pyridine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910225983.1A CN109957576A (en) | 2019-03-25 | 2019-03-25 | A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910225983.1A CN109957576A (en) | 2019-03-25 | 2019-03-25 | A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109957576A true CN109957576A (en) | 2019-07-02 |
Family
ID=67024789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910225983.1A Pending CN109957576A (en) | 2019-03-25 | 2019-03-25 | A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109957576A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423772A (en) * | 2019-07-17 | 2019-11-08 | 上海科技大学 | One kind being used for Acinetobacter bauamnnii cytosine base editor plasmid and its application |
CN114875046A (en) * | 2022-05-30 | 2022-08-09 | 福州大学 | Filamentous fungus replicon |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106834341A (en) * | 2016-12-30 | 2017-06-13 | 中国农业大学 | A kind of site-directed point mutation carrier and its construction method and application |
CN107619833A (en) * | 2017-08-14 | 2018-01-23 | 华中农业大学 | For building plasmid pZF17 30 and its construction method and the application of brucella mutant strain |
-
2019
- 2019-03-25 CN CN201910225983.1A patent/CN109957576A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106834341A (en) * | 2016-12-30 | 2017-06-13 | 中国农业大学 | A kind of site-directed point mutation carrier and its construction method and application |
CN107619833A (en) * | 2017-08-14 | 2018-01-23 | 华中农业大学 | For building plasmid pZF17 30 and its construction method and the application of brucella mutant strain |
Non-Patent Citations (2)
Title |
---|
LIANGGANG HUANG等: "Highly efficient single base editing in Aspergillus niger with CRISPR/Cas9 cytidine deaminase fusion", 《MICROBIOL RES》 * |
黄良刚: "黑曲霉基因组水平的转录调控机制研究", 《中国优秀博硕士学位论文全文数据库(博士)基础科学辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423772A (en) * | 2019-07-17 | 2019-11-08 | 上海科技大学 | One kind being used for Acinetobacter bauamnnii cytosine base editor plasmid and its application |
CN110423772B (en) * | 2019-07-17 | 2023-04-21 | 上海科技大学 | Cytosine base editing plasmid for Acinetobacter baumannii and application of cytosine base editing plasmid |
CN114875046A (en) * | 2022-05-30 | 2022-08-09 | 福州大学 | Filamentous fungus replicon |
CN114875046B (en) * | 2022-05-30 | 2023-07-18 | 福州大学 | Filamentous fungus replicon |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020207840B2 (en) | Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | |
CN106459957B (en) | Method for modifying genome sequence for specifically converting nucleic acid base of target DNA sequence, and molecular complex used therefor | |
Horwitz et al. | Efficient multiplexed integration of synergistic alleles and metabolic pathways in yeasts via CRISPR-Cas | |
CN109957576A (en) | A kind of pFC330-BEC plasmid being able to achieve the accurate point mutation of base and its application | |
KR20120099258A (en) | Engineering microbes for efficient production of chemicals | |
CN111763686B (en) | Base editing system for realizing C-to-A and C-to-G base mutation and application thereof | |
CN108753778B (en) | Repair of FBN1 by base editingT7498CMutational reagents and methods | |
CN111378679B (en) | Gene expression assembly, cloning vector constructed by same and application of cloning vector | |
WO1998022491A1 (en) | Method for identifying genes encoding novel secreted or membrane-associated proteins | |
CN108085286A (en) | The coltfoal shape bacillus spp. microorganism of cellulose production capacity with enhancing and its method for producing cellulose | |
US6673613B2 (en) | Use of CYP52A2A promoter to increase gene expression in yeast | |
CN101668418A (en) | Method for improvement of efficiency of transformation in plant, comprising co-culture step for culturing plant tissue in co-culture medium containing 3,6-dichloro-o-anisic acid | |
US20040161756A1 (en) | Substrate linked directed evolution (slide) | |
CN113088529B (en) | Novel beta-glucan gene HG278 and application thereof | |
CN101525627A (en) | Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof | |
CN114836455A (en) | Bacterial gene knockout plasmid containing rfp reporter gene and application thereof | |
KR101835852B1 (en) | Method for Genetic Engineering of Deinococcus Microorganisms Using Cre-lox System | |
CN111394384B (en) | Biosensor for detecting S-adenosylmethionine and preparation method thereof | |
KR101927892B1 (en) | Manufacturing method of mutant strain having increased phytoene productivity and mutant strain manufactured same | |
CN108138188A (en) | For the polynucleotide constructs of in vitro and in vivo expression | |
CN113354718A (en) | Piranin precursor, expression cassette and preparation method thereof | |
KR20200000804A (en) | Mutant strain having increased lycopene productivity | |
CN112626121B (en) | Antibody expression vector of triple screening mark and application thereof | |
CN114990149B (en) | Vector for traceless editing of target gene, construction and application thereof | |
CN110484560B (en) | Method for producing barren-resistant rice containing HVUL2H20083.2 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190702 |
|
RJ01 | Rejection of invention patent application after publication |